B

Biocentriq

www.biocentriq.com link_icon

Company Research Report: BioCentriq



Company Overview



General Information


  • Name: BioCentriq

  • Mission: To advance cell therapy manufacturing making life-altering medicines and therapeutics more accessible to patients.

  • Founded: 2019

  • Founder: Not specified

  • Key People:

  • Chathuranga De Silva, Ph.D., Executive Director, Business Development

  • David Smith, Ph.D., Vice President of Development

  • Mark Broadley, Vice President of Operations

  • Henry Han, Sr. Director, Finance

  • Gina Choi, Head of Human Resources

  • Headquarters: Newark, New Jersey

  • Number of Employees: 51-200 employees

  • Revenue: No information is available

  • Company Known For: BioCentriq is known for its expertise in cell therapy CDMO, advancing cell therapy from process development to clinical manufacturing phases.


Specifics


BioCentriq supports all stages of process development and cell therapy manufacturing with a collaborative, transparent, and attentive approach. They focus on early-stage autologous and allogeneic drug products, leveraging their LEAP™ Advanced Therapy Platform to help developers reach the clinical phase quickly.

Products and Services



LEAP™ Advanced Therapy Platform


  • Description: A platform to accelerate the path to clinic by minimizing up-front development costs and timelines.

  • Key Features:

  • Existing master batch records

  • Established SOPs

  • Qualified analytical methods

  • Trained personnel

  • Completed aseptic validation

  • Proven and reliable supply chain

  • Phase-appropriate quality system

  • Fit-for-purpose facilities and equipment


Manufacturing Services


  • Description: Production of drug products/drug substances for clinical trials with a focus on GMP manufacturing.

  • Key Features:

  • Hybrid team models

  • Global supply chain management

  • Newly constructed facilities

  • Robust quality systems


MS&T (Manufacturing, Science, and Technologies)


  • Description: Translating breakthrough medicines from bench to clinic.

  • Key Features:

  • Phase-appropriate tech transfer

  • De-risk innovative therapies with gap assessments

  • Documentation and training


Process Development


  • Description: Building robust, flexible, and scalable processes from the initial concept to clinical manufacturing readiness.

  • Key Features:

  • Quality-by-design strategy

  • End-to-end solutions

  • Analytical development

  • Upstream and downstream process development


Workforce Development


  • Description: Training programs designed to prepare the next generation of biopharma employees.

  • Key Features:

  • Custom-designed training labs

  • Face-to-face and virtual instructor-led training

  • Augmented and virtual reality programs


Recent Developments



New Products and Features


  • LEAP™ Advanced Therapy Platform launched in June 2023 which helps developers go from contract to clinic in six months.


Partnerships and Collaborations


  • Partnerships:

  • Terumo Blood and Cell Technologies: Joint research on public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms.

  • Autolomous: Partnership aimed at streamlining development and manufacturing using digital technologies.

  • Kytopen: Partnership for automation and scalable GMP manufacturing.

  • Premier Research: Strategic partnership to accelerate pre-IND timelines.


Events and Webinars


  • Hosting webinars on cell therapy such as "End-to-End Automated Manufacturing of Low-Seed CAR-T Cells."

  • Platinum sponsorship and participation in key industry events like the Cell & Gene Meeting on the Mesa (Oct 2024) and the Biomanufacturing World Summit (Nov 2024).


In News


  • Achievements Highlighted:

  • Frontrunners in automated cell and gene therapy manufacturing (PharmTech)

  • Digital transformation in advanced therapy manufacturing (The Medicine Maker)

  • Perspective on future advancements in cell & gene therapy manufacturing (Clinical Trials Arena)


Upcoming Events


  • Chardan’s 8th Annual Genetic Medicines Conference: September 30, 2024, New York City, NY.

  • Cell and Gene: Meeting on the MESA: October 07, 2024, Phoenix, AZ.

  • Biomanufacturing World Summit 2024: November 19, 2024, San Diego, CA.


Note: This report strictly outlines the data provided and does not include fields where no information was available.